子宫内膜异位症药物治疗研究进展  

Progress in research on pharmacotherapy of endometriosis

作　　者：郭方[1] 徐丛剑[1] 

机构地区：[1]复旦大学附属妇产科医院,上海200011

出　　处：《中国妇幼健康研究》2006年第6期510-513,共4页Chinese Journal of Woman and Child Health Research

摘　　要：随着对子宫内膜异位症传统药物治疗副作用的进一步认识,许多学者对传统治疗方案进行了补充与改进,包括促性腺激素释放激素激动剂的反向添加疗法,促性腺激素释放激素激动剂剂量、用药周期的调整等,同时亦积极探索新的治疗途径,如促性腺激素释放激素拮抗剂,含药物的宫内节育器,芳香化酶抑制剂,选择性雌激素受体调节剂,抗血管生成治疗等。现拟对这些内异症药物治疗的新进展作以综述。The pharmacotherapy of endometriosis is regarded as a challenge. With deeper recognition of the side effects of traditional pharmacotherapy,many scholars make some replenishments and improvements for their regimens of treatment, including GnRH-a add-back therapy,regulation of GnRH-a＇s dosage and medication cycle. Meanwhile, they also explore the new therapeutic route, such as GnRH antagonist, drug-loaded IUD, arimedex, selective estrogen receptor modulators, anti - angiogenesis therapy and so on. This article reviewed progress in research on pharmacotherapy of endometriosis.

关 键 词：子宫内膜异位症 药物 治疗 促性腺激素释放激素 

分 类 号：R711.71[医药卫生—妇产科学]